
Fuji Corporation manufactures and sells machines and machine tools in Japan. The company operates through Robotic Solutions and Machine Tools segment. It offers SMT equipment, including mounters, printers, inserters, automatic warehouses, software, and automatic maintenance units. In addition, the company provides machine tools comprising of LAPSYS, GYROFLEX, and DLFn, modular production equipment. Further, the company offers multijoint robot, such as robot cell series, SCARA, and articulated robot. Additionally, the company provides mobility support robot, atmospheric pressure plasma unit, and public stocker system. The company was formerly known as Fuji Machine Mfg. Co., Ltd. and changed its name to Fuji Corporation in April 2018. Fuji Corporation was founded in 1959 and is headquartered in Chiryu, Japan.
Fuji Corporation trades as FMMFF on OTC. The company is classified in Industrials / Industrial - Machinery and reports in USD.
The current profile places the business in Industrial - Machinery. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $181.78B of revenue and $15.83B of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Fuji Corporation can be compared against peers such as Bodycote plc, Chervon Holdings Limited, Clarkson PLC, Deutz AG, Imdex Limited, Krones AG.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $4.43B, beta of 1.20, and return on equity of +6.8%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
FMMFF currently shows total debt of $0 and beta of 1.20. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.fuji.co.jp
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.